A. Bader

Molecular Biology · 2005–2020

A researcher in the Science corpus: 10 papers; trusts 3 researchers and is trusted by 5 researchers here, as inferred from the citation graph.

Subfields

• Molecular Biology — 157 citations into it; #7,437 of 17,773 by trust here, #3,938 by citations
• Cancer Research — 108 citations into it; #558 of 1,780 by trust here, #592 by citations

Whom A. Bader trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. A. Esquela-Kerscher
2. T. Reya
3. George A. Calin
4. Matthias Selbach
5. N. Hay

Who trusts A. Bader overall

1. Scott M. Hammond
2. J. Engelman
3. Suzanne Schubbert
4. Romina Marone

Papers from A. Bader's perspective

Ordered by how strongly the researchers A. Bader trusts endorse each paper. Same corpus, a different order for every researcher.

1. Oncomirs — microRNAs with a role in cancer (Nature Reviews. Cancer)
2. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions (Nature Reviews. Cancer)
3. microRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes (Cancer Research)
4. MicroRNA signatures in human cancers (Nature Reviews. Cancer)
5. miR-34a repression of SIRT1 regulates apoptosis (Proceedings of the National Academy of Sciences of the United States of America)
6. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells (Oncogene)
7. RAS is regulated by the let-7 microRNA family. (Cell)
8. Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer (Cell Cycle)
9. Widespread changes in protein synthesis induced by microRNAs (Nature)
10. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. (Cell)

Their papers

• Oncogenic PI3K deregulates transcription and translation (2005) — 817 citations
• The let-7 microRNA reduces tumor growth in mouse models of lung cancer (2008) — 671 citations
• Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34 (2010) — 686 citations
• Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. (2005) — 851 citations
• Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice. (2011) — 668 citations
• miR-34 – a microRNA replacement therapy is headed to the clinic (2012) — 721 citations
• Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors (2016) — 788 citations
• Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours (2020) — 801 citations
• PDL1 Regulation by p53 via miR-34 (2015) — 653 citations
• Identification of miR-34a as a potent inhibitor of prostate cancer progenitor cells and metastasis by directly repressing CD44 (2011) — 1,193 citations